United Biomedical Inc. became the second Taiwanese COVID-19 vaccine developer to receive Food and Drug Administration (FDA) approval to begin a phase 2 clinical trial, the regulator said in statement released on Friday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Church, hiking group donate coats to New Taipei migrant fishers
02/23/2025 08:35 PM - Society
2025 Alishan Cherry Blossom Festival begins March 10
02/23/2025 07:37 PM - Politics
'Russia is the aggressor': Ukrainians in Taiwan tell the world at protest
02/23/2025 07:26 PM - Politics
Lai urges DPP lawmakers to see Trump's policies as an opportunity
02/23/2025 06:54 PM - Politics
Taiwan to review handling of religious objections to reserve duty
02/23/2025 06:42 PM